Literature DB >> 29102503

Maternal hemodynamics: a method to classify hypertensive disorders of pregnancy.

Enrico Ferrazzi1, Tamara Stampalija2, Lorenzo Monasta3, Daniela Di Martino4, Sharona Vonck5, Wilfried Gyselaers6.   

Abstract

BACKGROUND: The classification of hypertensive disorders of pregnancy is based on the time at the onset of hypertension, proteinuria, and other associated complications. Maternal hemodynamic interrogation in hypertensive disorders of pregnancy considers not only the peripheral blood pressure but also the entire cardiovascular system, and it might help to classify the different clinical phenotypes of this syndrome.
OBJECTIVE: This study aimed to examine cardiovascular parameters in a cohort of patients affected by hypertensive disorders of pregnancy according to the clinical phenotypes that prioritize fetoplacental characteristics and not the time at onset of hypertensive disorders of pregnancy. STUDY
DESIGN: At the fetal-maternal medicine unit of Ziekenhuis Oost-Limburg (Genk, Belgium), maternal cardiovascular parameters were obtained through impedance cardiography using a noninvasive continuous cardiac output monitor with the patients placed in a standing position. The patients were classified as pregnant women with hypertensive disorders of pregnancy who delivered appropriate- and small-for-gestational-age fetuses. Normotensive pregnant women with an appropriate-for-gestational-age fetus at delivery were enrolled as the control group. The possible impact of obesity (body mass index ≥30 kg/m2) on maternal hemodynamics was reassessed in the same groups.
RESULTS: Maternal age, parity, body mass index, and blood pressure were not significantly different between the hypertensive disorders of pregnancy/appropriate-for-gestational-age and hypertensive disorders of pregnancy/small-for-gestational-age groups. The mean uterine artery pulsatility index was significantly higher in the hypertensive disorders of pregnancy/small-for-gestational-age group. The cardiac output and cardiac index were significantly lower in the hypertensive disorders of pregnancy/small-for-gestational-age group (cardiac output 6.5 L/min, cardiac index 3.6) than in the hypertensive disorders of pregnancy/appropriate-for-gestational-age group (cardiac output 7.6 L/min, cardiac index 3.9) but not between the hypertensive disorders of pregnancy/appropriate-for-gestational-age and control groups (cardiac output 7.6 L/min, cardiac index 4.0). Total vascular resistance was significantly higher in the hypertensive disorders of pregnancy/small-for-gestational-age group than in the hypertensive disorders of pregnancy/appropriate-for-gestational-age group and the control group. All women with hypertensive disorders of pregnancy showed signs of central arterial dysfunction. The cardiovascular parameters were not influenced by gestational age at the onset of hypertensive disorders of pregnancy, and no difference was observed between the women with appropriate-for-gestational-age fetuses affected by preeclampsia or by gestational hypertension with appropriate-for-gestational-age fetuses. Women in the obese/hypertensive disorders of pregnancy/appropriate-for-gestational-age and obese/hypertensive disorders of pregnancy/small-for-gestational-age groups showed a significant increase in cardiac output, as well as significant changes in other parameters, compared with the nonobese/hypertensive disorders of pregnancy/appropriate-for-gestational-age and nonobese/hypertensive disorders of pregnancy/small-for-gestational-age groups.
CONCLUSION: Significantly low cardiac output and high total vascular resistance characterized the women with hypertensive disorders of pregnancy associated with small for gestational age due to placental insufficiency, independent of the gestational age at the onset of hypertension. The cardiovascular parameters were not significantly different in the women with appropriate-for-gestational-age or small-for-gestational-age fetuses affected by preeclampsia or gestational hypertension. These findings support the view that maternal hemodynamics may be a candidate diagnostic tool to identify hypertensive disorders in pregnancies associated with small-for-gestational-age fetuses. This additional tool matches other reported evidence provided by uterine Doppler velocimetry, low vascular growth factors in the first trimester, and placental pathology. Obesity is associated with a significantly higher cardiac output and outweighs other determinants of hemodynamics in pregnancy; therefore, in future studies on hypertensive disorders, obesity should be studied as an additional disease and not simply as a demographic characteristic.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  appropriate for gestational age; body mass index; cardiac output; cardiovascular hemodynamics; eclampsia; hypertensive disorders of pregnancy; obesity; preeclampsia; small for gestational age; total vascular resistance

Mesh:

Year:  2017        PMID: 29102503     DOI: 10.1016/j.ajog.2017.10.226

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

1.  The importance of the cerebroplacental ratio for the prognosis of neonatal outcome in AGA fetuses.

Authors:  L Mecke; A Ignatov; A Redlich
Journal:  Arch Gynecol Obstet       Date:  2022-05-22       Impact factor: 2.344

Review 2.  Hypertensive disorders and maternal hemodynamic changes in pregnancy: monitoring by USCOM® device.

Authors:  Elisa Montaguti; Gaetana Di Donna; Aly Youssef; Gianluigi Pilu
Journal:  J Med Ultrason (2001)       Date:  2022-06-15       Impact factor: 1.878

3.  Comparison of Hemodynamic and Biochemical Factors and Pregnancy Complications in Women with/without Preeclampsia.

Authors:  Banafsheh Mashak; Ramesh Baradaran Bagheri; Ghazal Noorani; Safoora Soleimanifakhr; Mina Ataei
Journal:  Maedica (Bucur)       Date:  2022-06

Review 4.  Maternal Venous Hemodynamic Dysfunction in Proteinuric Gestational Hypertension: Evidence and Implications.

Authors:  Wilfried Gyselaers
Journal:  J Clin Med       Date:  2019-03-11       Impact factor: 4.241

Review 5.  Cardiovascular System in Preeclampsia and Beyond.

Authors:  Basky Thilaganathan; Erkan Kalafat
Journal:  Hypertension       Date:  2019-03       Impact factor: 10.190

Review 6.  Acute Kidney Injury in Pregnancy: The Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Prevention and Care of Pregnancy-Related AKI, in the Year Dedicated to Women and Kidney Diseases.

Authors:  Giorgina Barbara Piccoli; Elena Zakharova; Rossella Attini; Margarita Ibarra Hernandez; Bianca Covella; Mona Alrukhaimi; Zhi-Hong Liu; Gloria Ashuntantang; Alejandra Orozco Guillen; Gianfranca Cabiddu; Philip Kam Tao Li; Gulliermo Garcia-Garcia; Adeera Levin
Journal:  J Clin Med       Date:  2018-10-01       Impact factor: 4.241

7.  Phenotypes of Pregnant Women Who Subsequently Develop Hypertension in Pregnancy.

Authors:  Kelsey McLaughlin; Jianhong Zhang; Stephen J Lye; John D Parker; John C Kingdom
Journal:  J Am Heart Assoc       Date:  2018-07-14       Impact factor: 5.501

Review 8.  Disruption in the Regulation of Immune Responses in the Placental Subtype of Preeclampsia.

Authors:  Janri Geldenhuys; Theresa Marie Rossouw; Hendrik Andries Lombaard; Marthie Magdaleen Ehlers; Marleen Magdalena Kock
Journal:  Front Immunol       Date:  2018-07-20       Impact factor: 7.561

9.  Study protocol for a prospective cohort study to investigate Hemodynamic Adaptation to Pregnancy and Placenta-related Outcome: the HAPPO study.

Authors:  Rianne C Bijl; Jérôme M J Cornette; Annemien E van den Bosch; Johannes J Duvekot; Jeroen Molinger; Sten P Willemsen; Anton H J Koning; Jolien W Roos-Hesselink; Arie Franx; Régine P M Steegers-Theunissen; Maria P H Koster
Journal:  BMJ Open       Date:  2019-11-10       Impact factor: 2.692

10.  Design of the Pregnancy REmote MOnitoring II study (PREMOM II): a multicenter, randomized controlled trial of remote monitoring for gestational hypertensive disorders.

Authors:  Dorien Lanssens; Inge M Thijs; Wilfried Gyselaers
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-15       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.